December 2021 • PharmaTimes Magazine • 4-5


Contents


Features

Meet the best of the best in 2021


The need for diversity and inclusion


A look at the digital landscape and rare cancer patients


The rise of the empowered patient


Improving client communications


Luca’s journey through diagnosis and treatment


Analysis

Finding a more holistic, outcomes-led strategy


The key developments this year


What’s next for the pharmaceutical industry?


Maintaining the industry’s pivotal role


The promise of gene therapy


SmartPeople

PharmaTimes talks to Janssen’s Vice President, Oncology, EMEA and Commercial Strategy Lead


13.
Thought Leadership
COUCH CEO Ash Rishi addresses implicit bias in clinical trials


29.
Thought Leadership
Advanz Pharma’s CEO Graeme Duncan reflects on 2021